Clinical Trial 45801

Portland, OR 97239


Study 45796 Flyer
This research study is testing investigational treatments (Lilotomab and Betalutin) to see how it works for people whose follicular lymphoma (FL) has returned.

Medical Condition: Follicular Lymphoma
Study duration: 5 years
Phase: IIb
Study locations: United States and Canada

Qualified Participants Must:

• Be at least 18 years of age
• Have a diagnosis of Follicular Lymphoma
• Have tried at least 2 treatments for FL
• Have used rituximab or Obinutuzumab

Qualified Participants May Receive:

Reimbursement for travel

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.